2.41

0.82% -0.02

After Hours: 2.40 -0.01 -0.41%

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $2.41, with a volume of 206.48K. It is down -0.82% in the last 24 hours and down -14.23% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$2.43

Open:

$2.45

24h Volume:

206.48K

Relative Volume:

0.38

Market Cap:

$224.91M

Revenue:

$25.14M

Net Income/Loss:

$-21.57M

P/E Ratio:

-8.9259

EPS:

-0.27

Net Cash Flow:

$-12.23M

1W Performance:

-2.03%

1M Performance:

-14.23%

6M Performance:

+7.59%

1Y Performance:

+15.87%

1-Day Range:

$2.375

$2.45

1-Week Range:

$2.21

$2.458

52-Week Range:

$1.54

$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1133)

Industry

Medical Instruments & Supplies (58)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2025-03-03

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	2.41	226.78M	25.14M	-21.57M	-12.23M	-0.27
ISRG Intuitive Surgical Inc	575.34	201.58B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	193.96	55.30B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	80.73	38.80B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	256.55	36.71B	5.26B	1.44B	1.76B	9.7713
WST West Pharmaceutical Services Inc	280.23	20.27B	2.96B	487.70M	344.00M	6.6758

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

Dec 05, 2025

Why Stereotaxis Inc. stock could be top winner2025 Earnings Impact & Daily Market Momentum Tracking - Newser

Dec 05, 2025

Is Stereotaxis Inc. stock vulnerable to rate hikesWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser

Dec 05, 2025

Why analysts maintain buy rating on Stereotaxis Inc. stock2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser

Dec 04, 2025

Can Stereotaxis Inc. stock hold up in economic slowdownOptions Play & Long-Term Investment Growth Plans - Newser

Dec 04, 2025

Dec 03, 2025